Royal Bank of Canada Purchases 119,714 Shares of Oscar Health, Inc. $OSCR

Royal Bank of Canada increased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 73.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 282,904 shares of the company’s stock after purchasing an additional 119,714 shares during the quarter. Royal Bank of Canada’s holdings in Oscar Health were worth $3,246,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in OSCR. Strs Ohio bought a new position in shares of Oscar Health in the first quarter valued at approximately $30,000. Jones Financial Companies Lllp lifted its holdings in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Quarry LP boosted its position in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after purchasing an additional 1,469 shares during the last quarter. Fifth Third Bancorp grew its stake in Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in Oscar Health in the 1st quarter valued at $49,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, CEO Mark T. Bertolini sold 624,244 shares of the business’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the sale, the chief executive officer owned 7,751,570 shares of the company’s stock, valued at $220,764,713.60. The trade was a 7.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider owned 259,057 shares in the company, valued at approximately $5,683,710.58. The trade was a 4.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 3,562,466 shares of company stock valued at $102,829,815. Insiders own 22.64% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of a number of recent analyst reports. Wolfe Research initiated coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating on the stock. Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday. Piper Sandler restated an “overweight” rating and set a $36.00 price objective on shares of Oscar Health in a report on Tuesday, July 28th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Finally, UBS Group boosted their target price on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health has an average rating of “Hold” and an average target price of $26.22.

Oscar Health Stock Performance

Shares of OSCR opened at $32.68 on Friday. The firm has a market cap of $10.09 billion, a PE ratio of 23.34, a PEG ratio of 0.67 and a beta of 2.36. The stock’s fifty day moving average price is $29.65 and its two-hundred day moving average price is $20.85. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.11. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $33.27.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The firm had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business’s revenue for the quarter was up 70.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.89) EPS. On average, equities research analysts forecast that Oscar Health, Inc. will post 1.54 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.